Brief: Genprex Announces Data From Non-Human Primate Study Evaluating Novel Gene Therapy To Treat Type 1 Diabetes
23/02/2023 12:19
Feb 23 (Reuters) - Genprex Inc GNPX.O :
* GENPREX INC- ANNOUNCES DATA FROM NON-HUMAN PRIMATE STUDY
EVALUATING NOVEL GENE THERAPY TO TREAT TYPE 1 DIABETES
* GENPREX INC- RESULTS SHOW STATISTICALLY SIGNIFICANT
DECREASES IN
INSULIN REQUIREMENTS AND IMPROVEMENTS IN GLUCOSE TOLERANCE
COMPARED TO BASELINE
Source text for Eikon: ID:nPn3Khw8Pa
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy